Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 61,579 shares at $5.02 ($313K) on 2023-12-05, disclosed to the SEC on 2023-12-05.
Open-market sale of $313k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.14 | 8,347 | $43K | 13.7% |
| 2 | $5.15 | 10,876 | $56K | 17.9% |
| 3 | $5.15 | 10,876 | $56K | 17.9% |
| 4 | $5.02 | 15,740 | $79K | 25.2% |
| 5 | $5.02 | 15,740 | $79K | 25.2% |
| Total | $5.08 avg | 61,579 |
| $313K |
| 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |